Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?

Author： Fiala K.H. Whetteckey J. Manyam B.V.

Publisher： Elsevier

ISSN： 1353-8020

Source： Parkinsonism and Related Disorders, Vol.9, Iss.6, 2003-08, pp. : 321-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malignant syndrome in Parkinson's disease

By Linazasoro G.

Parkinsonism and Related Disorders, Vol. 10, Iss. 2, 2003-12 ,pp. : 115-116

Elsevier

Access to resources Recommend Favorite

Management of levodopa-induced dyskinesias in Parkinson's disease

By Kashihara Kenichi

Journal of Neurology, Vol. 254, Iss. 5, 2007-09 ,pp. : 27-31

Springer Publishing Company

Access to resources Recommend Favorite

Levodopa inhibits habit-learning in Parkinson’s disease

By Fuhrer Hannah Kupsch Andreas Hälbig Thomas Kopp Ute Scherer Peter Gruber Doreen

Journal of Neural Transmission, Vol. 121, Iss. 2, 2014-02 ,pp. : 147-151

Springer Publishing Company

Access to resources Recommend Favorite

Piribedil as an adjunct to levodopa in advanced Parkinson's disease: the Asian experience

By Evidente V.G.H. Esteban R.P. Domingo F.M. Carbajal L.O. Parazo M.A.

Parkinsonism and Related Disorders, Vol. 10, Iss. 2, 2003-12 ,pp. : 117-121

Elsevier

Access to resources Recommend Favorite

Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease

By Calon F. Rajput A.H. Hornykiewicz O. Bedard P.J. Di Paolo T.

Neurobiology of Disease, Vol. 14, Iss. 3, 2003-12 ,pp. : 404-416

Elsevier

Access to resources Recommend Favorite